Xuebing Di

1.1k total citations
24 papers, 700 citations indexed

About

Xuebing Di is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xuebing Di has authored 24 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Xuebing Di's work include Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xuebing Di is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xuebing Di collaborates with scholars based in China, United States and United Kingdom. Xuebing Di's co-authors include Lin Feng, Ting Xiao, Kaitai Zhang, Shujun Cheng, Naijun Han, Yanning Gao, Liping Guo, Jianzhong Shou, Yi Zhang and Yipeng Wang and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Xuebing Di

24 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuebing Di China 13 355 226 197 175 164 24 700
Niki Arnogiannaki Greece 13 248 0.7× 210 0.9× 340 1.7× 158 0.9× 149 0.9× 44 781
Jen-Wei Tsai Taiwan 13 283 0.8× 110 0.5× 184 0.9× 251 1.4× 63 0.4× 13 588
Sébastien de Feraudy United States 13 277 0.8× 113 0.5× 174 0.9× 96 0.5× 76 0.5× 32 655
Linni Fan China 16 319 0.9× 186 0.8× 151 0.8× 93 0.5× 69 0.4× 50 649
Irena Klima Switzerland 11 233 0.7× 125 0.6× 157 0.8× 114 0.7× 37 0.2× 17 485
Kshitij S. Arora United States 13 284 0.8× 158 0.7× 254 1.3× 113 0.6× 59 0.4× 37 684
Jing-Hui Hou China 10 511 1.4× 334 1.5× 178 0.9× 66 0.4× 89 0.5× 12 721
Weihua Liang China 19 594 1.7× 321 1.4× 230 1.2× 164 0.9× 113 0.7× 54 893
T Osaki Japan 13 369 1.0× 131 0.6× 297 1.5× 215 1.2× 55 0.3× 28 663
Tove Øyjord Norway 9 268 0.8× 143 0.6× 350 1.8× 142 0.8× 108 0.7× 15 547

Countries citing papers authored by Xuebing Di

Since Specialization
Citations

This map shows the geographic impact of Xuebing Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebing Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebing Di more than expected).

Fields of papers citing papers by Xuebing Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebing Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebing Di. The network helps show where Xuebing Di may publish in the future.

Co-authorship network of co-authors of Xuebing Di

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebing Di. A scholar is included among the top collaborators of Xuebing Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebing Di. Xuebing Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yi, Liping Guo, Bingqing Shang, et al.. (2022). A signature for pan-cancer prognosis based on neutrophil extracellular traps. Journal for ImmunoTherapy of Cancer. 10(6). e004210–e004210. 133 indexed citations
2.
Feng, Lin, Yaru Wang, Yousheng Mao, et al.. (2022). Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma. Signal Transduction and Targeted Therapy. 7(1). 270–270. 11 indexed citations
3.
Li, Lin, Yi Zhang, Xin Nie, et al.. (2021). Prognostic value of the baseline circulating T cell receptor β chain diversity in advanced lung cancer. OncoImmunology. 10(1). 1899609–1899609. 5 indexed citations
4.
Wang, Jiaqi, Zekun Wang, Yang Liu, et al.. (2021). A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma. Cancer Immunology Immunotherapy. 71(3). 675–688. 5 indexed citations
5.
Zhang, Yajing, Xi Wu, Chengli Zhang, et al.. (2020). Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal‐type gastric cancer tumorigenesis. The Journal of Pathology. 251(2). 135–146. 32 indexed citations
6.
Guo, Liping, Wen Zhang, Lulin Zhou, et al.. (2019). A high-risk luminal A dominant breast cancer subtype with increased mobility. Breast Cancer Research and Treatment. 175(2). 459–472. 25 indexed citations
7.
Wen, Li, Liping Guo, Wen Zhang, et al.. (2019). Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients. Frontiers in Oncology. 9. 504–504. 30 indexed citations
8.
Zhang, Yajing, Fangfang Liu, Chengli Zhang, et al.. (2019). Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion. American Journal Of Pathology. 190(1). 37–47. 23 indexed citations
9.
Yu, Xuexin, Lin Feng, Zujing Han, et al.. (2016). Crosstalk of dynamic functional modules in lung development of rhesus macaques. Molecular BioSystems. 12(4). 1342–1349. 5 indexed citations
10.
Xu, Juan, Lin Feng, Zujing Han, et al.. (2016). Extensive ceRNA–ceRNA interaction networks mediated by miRNAs regulate development in multiple rhesus tissues. Nucleic Acids Research. 44(19). gkw587–gkw587. 52 indexed citations
11.
Wang, Junyi, et al.. (2015). Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives. Familial Cancer. 15(1). 99–104. 11 indexed citations
13.
Li, Lin, Jinjing Tan, Ying E. Zhang, et al.. (2014). DLK1 Promotes Lung Cancer Cell Invasion through Upregulation of MMP9 Expression Depending on Notch Signaling. PLoS ONE. 9(3). e91509–e91509. 57 indexed citations
14.
Shi, Xiaoyu, Yueming Zhang, Bangrong Cao, et al.. (2013). Genes involved in the transition from normal epithelium to intraepithelial neoplasia are associated with colorectal cancer patient survival. Biochemical and Biophysical Research Communications. 435(2). 282–288. 11 indexed citations
15.
Liu, Yu, Dongmei Lin, Ting Xiao, et al.. (2011). An immunohistochemical analysis‐based decision tree model for estimating the risk of lymphatic metastasis in pN0 squamous cell carcinomas of the lung. Histopathology. 59(5). 882–891. 7 indexed citations
16.
Li, Min, Ting Xiao, Ying Zhang, et al.. (2010). Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer. 69(3). 341–347. 49 indexed citations
17.
Li, Lin, Yu Liu, Minghui Wei, et al.. (2010). [DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx].. PubMed. 39(6). 391–5. 7 indexed citations
18.
Cai, Xiongwei, Ting Xiao, Sharon Y. James, et al.. (2009). Metastatic potential of lung squamous cell carcinoma associated with HSPC300 through its interaction with WAVE2. Lung Cancer. 65(3). 299–305. 17 indexed citations
19.
Zhang, Jianjun, Xuebing Di, Dong Wang, et al.. (2002). [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].. PubMed. 82(3). 161–3. 1 indexed citations
20.
Zhang, Jianjun, Shan Zheng, Yanning Gao, et al.. (2001). A comparison between microsatellite analysis and cytology of urine for the detection of bladder cancer. Cancer Letters. 172(1). 55–58. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026